Library

Language
Preferred search index
Number of Hits per Page
Default Sort Criterion
Default Sort Ordering
Size of Search History
Default Email Address
Default Export Format
Default Export Encoding
Facet list arrangement
Maximum number of values per filter
Auto Completion
Feed Format
Maximum Number of Items per Feed
feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Electronic Resource
    Electronic Resource
    Springer
    Annals of hematology 61 (1990), S. 303-306 
    ISSN: 1432-0584
    Keywords: ITP ; CFU-Meg ; DNA synthetic phase ; Megakaryocyte ; Platelet
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary The number and proliferative state of megakaryocyte progenitor cells (CFU-Meg) were compared between 13 patients with idiopathic thrombocytopenic purpura (ITP) and hematologically normal controls. The mean frequency of CFU-Meg assayed by the plasma clot method was 27.8 ± 12.2 (± SD)/2×105 bone marrow light-density cells for the ITP patients, which did not differ significantly from the control value of 31.9 ± 16.1. The percentage of CFU-Meg in DNA synthesis estimated by the3H-thymidine suicide technique was 41.3% ± 9.2% in ITP, which was significantly greater than the control value of 27.1% ± 7.4% (P 〈 0.01). The megakaryocyte counts for histological sections prepared from bone marrow aspirates from the ITP patients and controls were 34.5 ± 8.5/mm2 and 11.2 ± 5.8/mm2, respectively, with the difference being highly significant (P 〈 0.001). These results suggest that increased cycling activity in a quantitatively unchanged CFU-Meg pool may lead to increased megakaryocytes in the bone marrow of ITP patients.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...